RODOLFO IPPOLITI

About RODOLFO IPPOLITI

RODOLFO IPPOLITI, With an exceptional h-index of 32 and a recent h-index of 22 (since 2020), a distinguished researcher at Università degli Studi dell'Aquila,

His recent articles reflect a diverse array of research interests and contributions to the field:

Vesicular LGALS3BP is a neuroblastoma biomarker and a therapeutic target for combination therapy with antibody-drug conjugate and checkpoint inhibitors

Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma

Visualizing galectin-3 binding protein expression with immunoPET

Bio-Tailored Sensing at the Nanoscale: Biochemical Aspects and Applications

Recent Advances on Affibody-and DARPin-Conjugated Nanomaterials in Cancer Therapy

Hosts and Heterologous Expression Strategies of Recombinant Toxins for Therapeutic Purposes

Early-life exposure to environmentally relevant concentrations of triclocarban impairs ocular development in zebrafish larvae

HPLC-DAD validated method for DM4 and its metabolite S-Me-DM4 quantification in biological matrix for clinical and pharmaceutical applications

RODOLFO IPPOLITI Information

University

Position

Dept. of Life Health and Environmental Sciences

Citations(all)

3053

Citations(since 2020)

1642

Cited By

1936

hIndex(all)

32

hIndex(since 2020)

22

i10Index(all)

75

i10Index(since 2020)

45

Email

University Profile Page

Università degli Studi dell'Aquila

Google Scholar

View Google Scholar Profile

Top articles of RODOLFO IPPOLITI

Title

Journal

Author(s)

Publication Date

Vesicular LGALS3BP is a neuroblastoma biomarker and a therapeutic target for combination therapy with antibody-drug conjugate and checkpoint inhibitors

Cancer Research

Gianluca Sala

Emily Capone

Ilaria Cela

Giulio Lovato

Alessia Lamolinara

...

2024/3/22

Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma

Oral Oncology

Emily Capone

Vittoria Perrotti

Ilaria Cela

Rossano Lattanzio

Lucrezia Togni

...

2024/1/1

Visualizing galectin-3 binding protein expression with immunoPET

Molecular Pharmaceutics

Outi Keinänen

Samantha M Sarrett

Samantha Delaney

Cindy Rodriguez

Eric J Dayts

...

2023/5/16

Bio-Tailored Sensing at the Nanoscale: Biochemical Aspects and Applications

Francesca Fata

Federica Gabriele

Francesco Angelucci

Rodolfo Ippoliti

Luana Di Leandro

...

2023/1/13

Recent Advances on Affibody-and DARPin-Conjugated Nanomaterials in Cancer Therapy

Federica Gabriele

Marta Palerma

Rodolfo Ippoliti

Francesco Angelucci

Giuseppina Pitari

...

2023/5/12

Hosts and Heterologous Expression Strategies of Recombinant Toxins for Therapeutic Purposes

Luana di Leandro

Martina Colasante

Giuseppina Pitari

Rodolfo Ippoliti

2023/12/13

Early-life exposure to environmentally relevant concentrations of triclocarban impairs ocular development in zebrafish larvae

Chemosphere

Giulia Caioni

Carmine Merola

Cristiano Bertolucci

Tyrone Lucon-Xiccato

Beste Başak Savaşçı

...

2023/5/1

HPLC-DAD validated method for DM4 and its metabolite S-Me-DM4 quantification in biological matrix for clinical and pharmaceutical applications

Giulio Lovato

Luigi Ciriolo

Miryam Perrucci

Luca Federici

Rodolfo Ippoliti

...

2023/8/12

Truncating variants in the penultimate exon of TGFBR1 escaping nonsense-mediated mRNA decay cause Loeys-Dietz syndrome

European Journal of Human Genetics

Paola Fortugno

Rosanna Monetta

Valeria Cinquina

Chiara Rigon

Francesca Boaretto

...

2023/5

Extracellular LGALS3BP: a potential disease marker and actionable target for antibody–drug conjugate therapy in glioblastoma

Molecular Oncology

Beatrice Dufrusine

Emily Capone

Sara Ponziani

Rossano Lattanzio

Paola Lanuti

...

2023/8

Non-covalent inhibitors of thioredoxin glutathione reductase with schistosomicidal activity in vivo

Nature Communications

Valentina Z Petukhova

Sammy Y Aboagye

Matteo Ardini

Rachel P Lullo

Francesca Fata

...

2023/6/22

First non-covalent inhibitors of thioredoxin glutathione reductase with schistosomicidal activity in vivo

Valentina Petukhova

Samuel Aboagye

Matteo Ardini

Rachel Lullo

Margaret Byrne

...

2022/11/4

From immunotoxins to suicide toxin delivery approaches: is there a clinical opportunity?

Matteo Ardini

Riccardo Vago

Maria Serena Fabbrini

Rodolfo Ippoliti

2022/8/23

Biochemical and structural characterizations of thioredoxin reductase selenoproteins of the parasitic filarial nematodes Brugia malayi and Onchocerca volvulus

Redox Biology

Francesca Fata

Radosveta Gencheva

Qing Cheng

Rachel Lullo

Matteo Ardini

...

2022/5/1

Rational design and synthesis of a novel BODIPY-based probe for selective imaging of tau tangles in human iPSC-derived cortical neurons

Scientific Reports

Alessandro Soloperto

Deborah Quaglio

Paola Baiocco

Isabella Romeo

Mattia Mori

...

2022/3/28

EV20‑sss‑vc/MMAF, an HER‑3 targeting antibody‑drug conjugate displays antitumor activity in liver cancer

Oncology Reports

Daniela D'Agostino

Roberta Gentile

Sara Ponziani

Giulia Di Vittorio

Francesco Dituri

...

2021/2/1

Typical 2-cys Peroxiredoxin: applications of a morpheein in bionanotechnology

Matteo Ardini

Giorgia Giovannini

Nicolò Maccaferri

Xavier Zambrana-Puyalto

Gloria Panella

...

2021/7/1

PPARα-selective antagonist GW6471 inhibits cell growth in breast cancer stem cells inducing energy imbalance and metabolic stress

Biomedicines

Vanessa Castelli

Mariano Catanesi

Margherita Alfonsetti

Chiara Laezza

Francesca Lombardi

...

2021/1/28

Distance education during COVID 19: an Italian survey on the university teachers’ perspectives and their emotional conditions

BMC medical education

Massimo Casacchia

Maria Grazia Cifone

Laura Giusti

Leila Fabiani

Roberto Gatto

...

2021/6/9

Taking advantage of the morpheein behavior of peroxiredoxin in bionanotechnology

Matteo Ardini

Andrea Bellelli

David L Williams

Luana Di Leandro

Francesco Giansanti

...

2021/1/7

See List of Professors in RODOLFO IPPOLITI University(Università degli Studi dell'Aquila)

Co-Authors

H-index: 112
ANTONIO GIORDANO

ANTONIO GIORDANO

Temple University

H-index: 62
Sandro Santucci

Sandro Santucci

Università degli Studi dell'Aquila

H-index: 52
Anders Rosén

Anders Rosén

Linköpings Universitet

H-index: 41
Giovanni Antonini

Giovanni Antonini

Università degli Studi Roma Tre

H-index: 37
Sandra Moreno

Sandra Moreno

Università degli Studi Roma Tre

H-index: 23
Francesco Giansanti

Francesco Giansanti

Università degli Studi dell'Aquila

academic-engine